🇺🇸

US SEC Filing Intelligence

· daily

High-Value Federal Grants ($5M+) — August 19, 2026

The two contracts in this digest total $444.6 million, both civilian, with zero defense exposure, underscoring a non-DOD procurement focus. The dominant signal is a $270.4 million ICE detention compliance award to GEO Group subsidiary B.I. Incorporated, representing a high-conviction bullish signal for GEO Group given its materiality (8/10) and full competition win. A separate $174.1 million FCC sole-source contract to non-public Universal Service Administrative Company (USAC) offers limited actionable insight. Key risk: GEO Group's fixed-price structure on the ICE contract carries medium performance risk, and the contract's 14-month duration with no options creates a re-compete cliff in September 2025.

2 total filings
· daily

General Federal Contracts — August 19, 2026

The two contracts in this digest total $444.6 million in obligations, both civilian (0% defense), with the Department of Homeland Security (ICE) and the Federal Communications Commission as the awarding agencies. The dominant signal is a $270.4 million firm-fixed-price delivery order to GEO Group subsidiary B.I. Incorporated for ICE's Intensive Supervision Appearance Program (ISAP IV), representing a high-conviction bullish catalyst for GEO Group given its materiality (8/10) and 14-month revenue stream. A second, $174.1 million sole-source contract to nonprofit Universal Service Administrative Company (USAC) for FCC administrative support is neutral for public investors due to USAC's non-public status. Key risk: the fixed-price structure of the GEO Group contract carries medium performance risk, and the contract expires September 2025 with no options, creating a re-compete overhang.

2 total filings
· daily

S&P 500 Technology Sector SEC Filings — August 19, 2026

The 18 filings from the S&P 500 Technology sector reveal a bifurcated landscape: Analog Devices (ADI) is posting explosive growth (revenue +40% YoY, net income +158%), driven by Data Center and Industrial demand, but its massive $1.157B buyback in one quarter raises capital allocation sustainability questions. Marvell Technology's strategic custom-chip deal with Google (warrant for up to 58.97M shares tied to $500M revenue tranches) signals a deep, long-term AI infrastructure partnership that could reshape its revenue profile. Insider activity is mixed: ADI executives had routine tax-withholding sales (no open-market selling), while Cadence and Palantir insiders executed pre-planned 10b5-1 sales totaling ~$2M, indicating no alarm but no incremental bullish conviction. ServiceNow insiders also exercised and withheld shares at $117.70, a routine pattern. Overall, the sector shows strong AI-driven demand, but capital allocation discipline and insider sentiment warrant close monitoring.

16 high priority 2 medium 18 total filings
· daily

Nasdaq 100 Stocks SEC Filings — August 19, 2026

The 18 filings from NASDAQ-100 constituents reveal a bifurcated landscape: Analog Devices (ADI) delivered a standout quarter with 40% YoY revenue growth and 68% adjusted EPS expansion, driven by Data Center and Industrial demand, yet its massive $1.157B buyback in a single quarter raises questions about capital allocation sustainability. Insider activity is heavily skewed toward selling, with 11 filings showing disposals—most notably CoreWeave’s Chief Development Officer liquidating nearly all his holdings for ~$5.7M, and Palantir’s director selling $1.31M—while only one insider purchase (Linde director buying $48K) offers a contrarian bullish signal. Period-over-period trends highlight ADI’s margin expansion (GAAP gross margin +520 bps, adjusted operating margin +780 bps) as a key positive, but the lack of guidance updates across filings limits forward visibility. The overall theme is one of strong operational performance at ADI contrasting with broad insider skepticism, particularly in high-growth names like CoreWeave and Palantir, suggesting near-term caution may be warranted.

15 high priority 3 medium 18 total filings
· daily

US Activist Hedge Fund Institutional SEC 13D 13G — August 19, 2026

This digest of 41 SEC filings reveals a significant uptick in activist and institutional activity centered on M&A, insider selling, and passive stake accumulation. The most critical development is the $7.40/share take-private of Weave Communications by Francisco Partners, a high-conviction event with a 9/10 materiality score. A bearish theme emerges from major insider selling, including Uber's 72M share block sale in Aurora Innovation (dropping to 10.9% ownership) and General Atlantic's $134M dLocal stake reduction. Conversely, we see aggressive accumulation by the Winklevoss entities in Cypherpunk Technologies (19.9% stake) and a new 5.6% passive position in Grocery Outlet by Pertento Partners. Period-over-period comparisons highlight a trend of dilution-driven ownership decreases, as seen in Camp4 Therapeutics and Silexion Therapeutics, the latter also embroiled in a high-stakes legal dispute over share validity. The data also reveals a pattern of SPAC sponsor filings (OceanLight, Futurewave, Pelican) with no announced targets, signaling a watchful period for de-SPAC catalysts. Overall, the stream points to a market where large holders are actively rebalancing portfolios, with a clear bias toward monetizing positions in growth-stage companies while selectively building stakes in special situations and value-oriented plays.

17 high priority 24 medium 41 total filings
· daily

S&P 500 Financials Sector SEC Filings — August 19, 2026

The six filings from the S&P 500 Financials sector reveal a mixed picture with notable insider selling and capital-raising activities. Insider selling is a dominant theme, with executives and major holders at American Express, Robinhood Markets, Robinhood Ventures Fund I, and AFLAC all reducing positions, totaling over $3.5 million in sales. This pattern, though partly under 10b5-1 plans, signals potential caution among corporate insiders. In contrast, Wells Fargo is proactively raising capital through a new $1.75 billion preferred stock issuance, indicating a strategic focus on bolstering its balance sheet. Progressive Corp provided a routine monthly update with no specific figures, offering limited actionable insight. The overall sentiment is cautious, with insider activity and capital allocation decisions pointing toward a defensive posture among major financial institutions.

5 high priority 1 medium 6 total filings
· daily

S&P 500 Energy Sector SEC Filings — August 19, 2026

The six filings for the S&P 500 Energy stream are dominated by insider trading activity, revealing a pronounced bearish sentiment from senior officers across major integrated and service companies. A clear trend emerges of executives at Chevron and Halliburton cashing out significant equity stakes, including CEO-level sales, which contrasts with a minor, likely symbolic, purchase by a major holder at Texas Pacific Land Corp. There are no period-over-period financial comparisons, forward-looking guidance, capital allocation changes, or transaction details available in any filing, limiting the ability to assess operational trends. The most actionable signal is the concentrated, high-dollar insider selling at Chevron and Halliburton, which strongly suggests near-term caution on stock valuations from the management teams. For investors, this cluster of insider sales is a material risk flag, while the lack of any broad-based buying or positive operational catalysts keeps the sector theme cautious.

6 high priority 6 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — August 19, 2026

The five filings in the S&P 500 Consumer Staples sector reveal a bifurcated landscape: retailers and personal care companies are showing strong top-line recovery and margin expansion, while food companies face headwinds. Target Corporation and Estée Lauder Companies both reported accelerating sales growth and significant profitability improvements, with Target's Q2 2026 EPS more than doubling YoY (including a $1.65 tariff refund benefit) and Estée Lauder's adjusted operating margin expanding 320 bps. However, both carry 'mixed' sentiment due to rising costs (Target's SG&A rate up 30 bps) and one-time charges (Estée Lauder's $813M restructuring). In contrast, Hershey's insider selling by the 10% owner trust (8,184 shares sold via 10b5-1 plan) signals potential headwinds for the confectionery giant, while Archer-Daniels-Midland's executive stock award (259,935 shares to COO) suggests retention rather than growth conviction. The overarching theme is a consumer shift toward value and essentials, with Target's Food & Beverage (+7.2%) and Beauty (+7.2%) categories outperforming, and Estée Lauder's Fragrance (+12%) leading its recovery. Portfolio-level trends show revenue growth averaging 5% across reporting companies, but margin trajectories diverge sharply between retailers and food producers.

3 high priority 2 medium 5 total filings
· daily

S&P 500 Industrials Sector SEC Filings — August 19, 2026

The six filings from the S&P 500 Industrials stream reveal a sector characterized by significant insider profit-taking and leadership transitions, while balance sheet management remains defensive. Three separate insider sales events (Parker-Hannifin, RTX, Johnson Controls) totaling over $4.8 million suggest management is capitalizing on elevated valuations or signaling caution, particularly in the aerospace and fluid power sub-sectors. In contrast, Boeing's CFO tax withholding is routine and neutral. Honeywell's leadership reshuffle highlights a strategic push to sustain high-single-digit organic growth in Building Automation, while 3M's renewal of a $4.25 billion credit facility underscores a focus on liquidity and covenant discipline. No period-over-period financial trends (e.g., revenue growth or margin compression) were directly reported in these filings, limiting cross-company trend analysis, but the insider activity pattern is a notable sector-level signal.

6 high priority 6 total filings
· daily

US Material Events SEC 8-K Filings — August 19, 2026

The 50 filings reveal a dynamic market landscape with significant M&A activity, strategic financings, and leadership transitions. Key themes include a surge in SPAC-related transactions (Oceanhawk, Viking, Karman Line), aggressive capital raises via convertible notes (Datavault AI, Opendoor) and ATM offerings (FrontView, XCel), and notable M&A deals (Harte Hanks, Weave, Datavault AI). Period-over-period data shows mixed financial health: some companies like Ameresco reaffirm strong guidance, while others like Arrive AI face distress. Insider activity is limited but includes performance-based CEO grants (Unity, Envista) signaling alignment. Capital allocation trends show debt refinancing (Newell, Griffon) and balance sheet strengthening (Saratoga). Forward-looking catalysts include clinical trial readouts (Longeveron) and M&A closings (Destination XL). Overall, the market is active with both opportunities and risks, particularly in high-growth tech and SPAC sectors.

50 high priority 50 total filings
· daily

Insider Trading Pulse — August 19, 2026

The August 19, 2026, insider trading digest reveals a pronounced bearish tilt, with 22 sell transactions from corporate insiders totaling over $27 million, dwarfing $3.5 million in insider buys. The most concentrated selling occurred at Sea Ltd, where five top executives (CFO, COO, Presidents) collectively cashed out over $4.7 million under 10b5-1 plans, signaling a potential peak sentiment in the tech sector. Conversely, a few high-conviction insider purchases stand out, including a $1.44 million buy by CCH Holdings' Chairman/CEO/COO and a $207K purchase by American Coastal Insurance's COO, suggesting deep value plays. The data shows a clear divergence: growth/tech insiders are taking profits, while insiders at small/mid-cap value and special situation companies are deploying capital. Key period-over-period trends are limited in this single-day snapshot, but the sheer volume of selling at Sea Ltd and Marathon Petroleum ($2.58M) warrants close monitoring for sector-wide de-risking.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — August 19, 2026

The August 19, 2026 batch of Dow 30 filings is dominated by insider transactions, with three notable sell-side events from senior executives at American Express, Sherwin-Williams, and Chevron, totaling over $11M in realized proceeds. While these sales are partially explained by option exercises and tax planning, the sheer volume and proximity raise a cautionary flag on management conviction at these specific companies. In contrast, Amazon's insider sale was executed under a pre-arranged 10b5-1 plan, reducing its signal value. The two operational filings (3M and Honeywell) are neutral, focusing on routine credit facility renewals and leadership transitions, respectively. No period-over-period financial trends or forward-looking guidance changes were present in this batch, limiting the ability to identify portfolio-level growth or margin trends. The key takeaway is a moderate insider selling bias across the industrials and financials sectors, warranting closer scrutiny of upcoming earnings calls for these names.

8 high priority 8 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — August 19, 2026

The August 19, 2026 corporate distress landscape is dominated by acute delisting risks at two micro-cap biotech firms, Skye Bioscience and OSR Holdings, both of which received Nasdaq Staff Determinations. Skye faces a fundamental solvency crisis with negative stockholders' equity (-$497K vs. a $2.5M minimum), while OSR faces an imminent trading suspension on August 26 due to a chronic bid price deficiency, despite a massive, anomalous trading spike (370M shares on Aug 17). In contrast, Mereo BioPharma has been granted a second 180-day extension to cure its bid price deficiency, providing a longer runway until February 2027. The fourth filing, Trio-Tech International, is a voluntary, non-distressed listing transfer from NYSE American to Nasdaq, representing a neutral, administrative event. The key portfolio-level pattern is a bifurcation between companies with fundamental equity insolvency (Skye) and those with purely market-price-driven compliance issues (OSR, Mereo), with the former presenting a materially higher risk of permanent delisting. Insider activity data was absent from all filings, limiting conviction signals, but the forward-looking data creates a clear catalyst calendar of hearings and deadlines.

4 high priority 4 total filings
· daily

Global High-Priority Regulatory Events — August 19, 2026

This digest of 50 SEC filings from August 19, 2026, reveals a market sharply bifurcated between distressed situations and strategic M&A. A cluster of 10 SPAC filings, including a $200 million IPO (Karman Line) and several delistings (Artius II, Xos warrants), highlights the ongoing churn in the blank-check sector. The most critical developments are the near-completion of the $77/share acquisition of Forte Biosciences by argenx, a high-risk delisting notice for Skye Bioscience, and a massive $1.0 billion token deal for Flora Growth Corp. On the distressed side, three Indian companies (AGS Transact, Setubandhan, Zicom) are in active insolvency, while two iShares ETFs were voluntarily liquidated. Insider activity is notably absent across the filings, but forward-looking data points to several key catalysts, including shareholder votes and compliance deadlines. The overarching theme is capital allocation under pressure: companies are either aggressively pursuing transformative M&A, winding down, or fighting for survival.

50 high priority 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — August 19, 2026

The four filings from S&P 500 Consumer Discretionary constituents reveal a sector bifurcating between off-price and home improvement winners and e-commerce/retail laggards. TJX Companies delivered a standout quarter with 24% EPS growth and raised full-year guidance, though its core Marmaxx segment and Canada business showed deceleration, signaling potential saturation risk. Lowe's reported a fifth consecutive quarter of positive comparable sales but saw operating margin contract 81 bps and narrowed its full-year outlook, reflecting persistent DIY headwinds and tariff uncertainty. Insider activity at Amazon showed a top executive selling nearly $500K in stock under a 10b5-1 plan, which, while pre-planned, adds to a pattern of insider selling at the company. Marriott's filing was a routine tax withholding event with no actionable signal. The overarching theme is that off-price retail is gaining share, while home improvement faces a demand trough, and e-commerce insiders are reducing exposure.

2 high priority 2 medium 4 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — August 19, 2026

The three S&P 500 Healthcare filings for August 19, 2026, present a mixed picture: insider selling at Centene and Intuitive Surgical contrasts with a neutral leadership change at Baxter. Centene's General Counsel sold a material $3.1M stake, signaling potential bearish sentiment from a key insider, while Intuitive Surgical's EVP executed a small, pre-planned sale of $90K, which is less concerning. Baxter's appointment of a new CFO with strong transformation experience and reaffirmed full-year guidance provides stability. No period-over-period financial trends or forward-looking guidance changes were available from these filings, limiting trend analysis. The primary actionable intelligence centers on insider activity and corporate governance signals, with Baxter's leadership transition being the most significant event for future strategic direction.

3 high priority 3 total filings
· daily

US Earnings Financial Results SEC Filings — August 19, 2026

The 50 filings for the period ending August 19, 2026, reveal a deeply bifurcated market. While a handful of established companies like Analog Devices and Brinker International posted strong, operationally-driven growth, the vast majority of filers—particularly small-cap and micro-cap entities—are reporting severe financial distress. A dominant theme is the 'revenue mirage' where top-line growth is driven by one-time gains, acquisitions, or non-cash items, masking underlying operational deterioration. This is exemplified by Atlantic International Corp., whose revenue surged 211% from an acquisition while its net loss ballooned to $86.4M. The data also highlights a 'cash crunch' crisis, with 10+ companies reporting critically low or zero cash balances, including Nutra Pharma Corp and Kinetic Seas Inc. Insider trading activity was notably absent from the enriched data, but forward-looking statements from Ocean Power Technologies include a material going concern warning, a significant red flag. Capital allocation trends are mixed, with Flexsteel Industries aggressively buying back stock while others like KALA BIO are forced into reverse stock splits to maintain listings. The overall picture is one of extreme caution, where investors must rigorously distinguish between genuine, sustainable growth and accounting-driven illusions.

50 high priority 50 total filings
· daily

US Executive Compensation Proxy SEC Filings — August 19, 2026

The six proxy filings reveal a bifurcated market: two high-materiality corporate actions (Columbus Acquisition's SPAC merger and Hancock Park's liquidation) contrast with four routine governance documents. Columbus Acquisition's merger with WISeSat.Space carries significant uncertainty due to undisclosed cash and redemption levels, while Hancock Park's wind-down signals a definitive exit. BayFirst Financial and Advent Convertible & Income Fund present standard proposals with no major financial or strategic changes. OneMedNet's reverse stock split and equity plan increase suggest a proactive balance sheet restructuring. Howard Hughes Holdings stands out with positive sentiment, driven by Pershing Square's $900M investment and strong 2025 results, indicating a transformative period. Across the portfolio, no clear sector-wide trends emerge, but the mix of liquidation, merger, and routine governance underscores diverse corporate lifecycles. Key period-over-period data is limited, but forward-looking events (meetings in September and October) provide a catalyst calendar for investors.

6 high priority 6 total filings
· daily

US IPO Pipeline SEC S-1 Filings — August 19, 2026

The IPO pipeline this period is thin with only two filings, but they represent divergent paths: a speculative renewable fuels IPO (XCF Global) and a routine corporate redomiciling (Genpact). XCF Global's S-1 reveals a high-risk growth story with revenue surging 52.9% YoY but persistent net losses and a deep accumulated deficit of $24.4M, signaling a capital-intensive venture with no path to profitability yet. Genpact's S-4 is a non-offering, administrative domestication with no financials and neutral sentiment, offering no trading or valuation signals. The overarching theme is a lack of high-quality, profitable IPOs entering the pipeline, with XCF's mixed sentiment and material financial red flags suggesting caution for yield-oriented investors. The data underscores a razor-thin pipeline where most activity is structural (redomiciling) rather than capital formation, reinforcing a risk-off posture toward new issuances until more mature, cash-flow-positive filers emerge.

2 high priority 2 total filings
· daily

US SEC Trading Suspension Halt Orders — August 19, 2026

The August 19, 2026 trading suspension landscape is dominated by two acute delisting events (Skye Bioscience and OSR Holdings) that signal severe financial distress and imminent liquidity crises for micro-cap biotech and health companies. Skye Bioscience faces a Nasdaq delisting due to negative stockholders' equity (-$497K vs. $2.5M minimum), while OSR Holdings will be suspended from trading on August 26 after failing to maintain the $1.00 bid price for two consecutive compliance periods. In contrast, Mereo BioPharma has been granted a second 180-day extension (until Feb 2027) to regain compliance, and Trio-Tech International is voluntarily transferring its listing from NYSE American to Nasdaq, representing a neutral, non-distressed event. The key portfolio-level pattern is a bifurcation between companies with viable paths to compliance (Mereo, Trio-Tech) and those facing near-certain delisting (Skye, OSR). No insider trading activity, capital allocation changes, or forward-looking guidance were reported in any of the filings, limiting the depth of trend analysis but highlighting the reactive, compliance-driven nature of these events.

4 high priority 4 total filings